Post by QIAGEN

A fast automated nucleic acid extraction workflow is only half the story. The harder question is whether it can handle what comes next: a new sample type, a different target or a matrix that brings its own inhibitors into the workflow. In our latest newsletter, we look at why automated nucleic acid preparation needs more than throughput, and how QIAsprint Connect combines high-throughput automation with flexible chemistry that adapts to changing applications.